Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp - Test2 - elhamkhani - TriplyDB

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

http://www.wikidata.org/entity/Q34426585

about

Transmission dynamics and control of Ebola virus disease (EVD): a review The 2014–2015 Ebola outbreak in West Africa: Hands On Monitoring of Ebola Virus Makona Evolution through Establishment of Advanced Genomic Capability in Liberia Ebola virus disease and critical illness.The potential of plants as a system for the development and production of human biologics Biomanufacturing of protective antibodies and other therapeutics in edible plant tissues for oral applications Plants as Factories for Human Pharmaceuticals: Applications and Challenges Ebolavirus Evolution: Past and Present Production of monoclonal antibodies in plants for cancer immunotherapy The Engineered Chloroplast Genome Just Got Smarter Filoviruses: One of These Things is (not) Like the Other Fc receptors and their influence on efficacy of therapeutic antibodies for treatment of viral diseases Co-evolution of the MHC class I and KIR gene families in rhesus macaques: ancestry and plasticity Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks Ebolavirus comparative genomics Pre-symptomatic diagnosis and treatment of filovirus diseases Ebola Virus Disease: Focus on Children Plant-based solutions for veterinary immunotherapeutics and prophylactics Antiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposure Ebolavirus Glycoprotein Directs Fusion through NPC1+ Endolysosomes Systems Biology-Based Investigation of Cellular Antiviral Drug Targets Identified by Gene-Trap Insertional Mutagenesis Converting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into play Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies Structural and molecular basis for Ebola virus neutralization by protective human antibodies Cell-targeting antibodies in immunity to Ebola Oral Delivery of Protein Drugs Bioencapsulated in Plant Cells Ebola: translational science considerations Molecular pharming's foot in the FDA's door: Protalix's trailblazing story Clomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic Implications Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA Preparing for Serious Communicable Diseases in the United States: What the Ebola Virus Epidemic Has Taught Us Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea A Rapid Screening Assay Identifies Monotherapy with Interferon-ß and Combination Therapies with Nucleoside Analogs as Effective Inhibitors of Ebola Virus Production of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal Cattle Offering patients more: how the West Africa Ebola outbreak can shape innovation in therapeutic research for emerging and epidemic infections Ebola Viral Disease in West Africa: A Threat to Global Health, Economy and Political Stability Ebola virus disease: What clinicians in the United States need to know.Progress of vaccine and drug development for Ebola preparedness Disease Prevention: An Opportunity to Expand Edible Plant-Based Vaccines?Insights from clinical research completed during the west Africa Ebola virus disease epidemic.

P2860

Q21146685-76C42A0D-B424-4A8F-803C-449B56DDC6D3 Q24049114-FC04350F-CF57-4574-BFE7-B066CF5CD57F Q24696012-2BEF5D48-40A5-4484-AD64-0661AF2FFF24 Q26250274-9787EC72-027C-4B29-817B-B5E8DFBE0E45 Q26747611-DE0CD400-2A11-49E5-998B-493004C6D2F6 Q26766215-2E7E44D9-ECBA-44D2-A75D-549A30BDEF65 Q26775069-A3DF86F9-DB9E-4CAA-B8E6-7890367AF7FD Q26777336-E43ECB1E-0022-4B53-B153-A9A326AC6F6C Q26778423-E1F30333-0A2F-40CD-AE30-1863C74789A1 Q26781748-06F59B5D-1045-4020-B8B1-D8C935674269 Q26783063-87A6E2C7-8DA3-4452-839C-94BF3FFF1761 Q26783175-B2A9A27B-4AE9-4B5E-96D5-EA1C2DA4196E Q26797239-E99F3166-80BF-496B-8B00-2F6158F71AE0 Q26801423-9E1BACE3-5DB5-4CC4-BD23-16A0374B35AB Q26801790-9419B2C7-D7C8-4CB9-95D3-D2341949CA5B Q26823831-5E6F1655-C776-428A-A1C8-CC695394CA19 Q26824080-AF0A30C7-7C1B-482C-B0C3-EC7272F342AB Q27000876-E3BBD02F-BAB1-4323-AED2-3E34DACB57CF Q27304441-EA789F90-3208-4D6B-9FDA-49AF8EDCE68A Q27321283-2DA969EA-4166-40CF-AE95-DC0410388DB5 Q27468694-E34570D5-0EEC-493E-BF5B-E8FF7F64ABD3 Q27468870-7B6D19C2-E9FD-46BA-801A-CBB48C8154FC Q27704173-4F8BCFF0-B242-42E9-8E00-41F7CF9EA228 Q27704188-229B02D4-44EE-4018-836B-6D8852EC4E37 Q28068972-C8D81081-70BA-4F49-9E26-48D9690FCC0A Q28079063-95ACA77D-D830-49C6-8456-6D5CC06ABF43 Q28082994-35AB732E-B802-40E2-9807-7B7FE7865B9C Q28086959-831865E9-FBBF-41C0-A4E3-300196E983D2 Q28387522-6F33E0E0-0410-45E5-AE0C-5A7AAD99292C Q28396399-432529F5-34DA-48A4-AA64-1B501AE0F502 Q28397866-9261E717-965E-470E-B3EB-069E6BD961E9 Q28550455-7878EB0C-ED4F-425E-BEEB-FE024B560CA6 Q28552295-C2EBF409-681A-431E-A42E-69BFF82172E8 Q28603849-DA5F1B90-4175-44C9-BB66-0DAAA646F20D Q29994672-71D244C0-8D79-42F5-850D-9BC8189D6FE6 Q30148821-12F3640E-A53C-4612-A1E9-12CAC81E704D Q30203249-8F670184-6F54-4D5E-BD78-E30E0725C601 Q30204870-5EBC7448-1D22-485A-BED3-5F10EF36BBA7 Q30234320-69696D2D-4592-46C9-A217-2B0E06F89EA6 Q30234590-A0006AC6-59A6-4B72-8A67-40E46C63C6AC

P2860

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

http://www.wikidata.org/entity/Q34426585

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

@ast

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

@en

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

@nl

type

label

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

@ast

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

@en

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

@nl

prefLabel

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

@ast

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

@en

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

@nl

P1433

Q34426585-9F0425B5-22A6-4690-BF28-8A8D284751A7

P1476

Q34426585-B5DDE215-FB2B-4756-AB1F-ADF40AD998AD

P2093

Q34426585-1DD04399-E486-4717-80E8-DAC732B61817

Q34426585-2113D663-2557-4295-AA3D-7970BAF2F8B3

Q34426585-28114F39-311A-4F1E-BA31-48120B785B84

Q34426585-36729D63-17DF-4920-97B3-7E5804855675

Q34426585-376BC252-A060-49D7-AA42-DD6EBFD6233B

Q34426585-3C3D7DC1-FA46-46FA-BF3B-2DC6E227F8F7

Q34426585-3DB3684E-E8C4-4242-935F-83F6B0044FBB

Q34426585-66FAC10B-CBF0-4790-88E0-2EC76D650636

Q34426585-6D874CC7-D767-443A-85A2-C970CF029E89

Q34426585-72BE6CDB-2495-4B83-84EC-E055A1E4FBF6

P2860

Q34426585-00239DFD-EA17-4500-99DC-5C5282A9A925

Q34426585-046D5B1E-6173-4D6E-86A9-20BC5ED6A8D9

Q34426585-0AEE3B94-F24C-45D2-89E6-08204C7A40ED

Q34426585-140532E7-D3C7-4788-AB00-E575CA193DEA

Q34426585-187EA273-841F-4E92-9EDC-D8927D27562B

Q34426585-2A32E951-F4D5-4EC0-8E6B-2D1D43A9C02E

Q34426585-3E9B8B20-05C0-4921-B391-AF0938B2AAE5

Q34426585-414A6F81-0D7B-4D96-A6A5-CD2BF889F3DC

Q34426585-480C8338-D0AB-4935-85BC-E17DDA56BBDB

Q34426585-714818D3-94DA-46DF-AD46-669C35A6BE93

P2888

Q34426585-5DE6CD24-8C6D-4173-9CDD-AF9D2AAD04E2

P304

Q34426585-264DC1D5-98F9-4A9C-B5F4-EB0EA80FA020

P31

Q34426585-908A109C-E893-452A-98E9-FB471C057525

P356

Q34426585-B6ED6883-9A06-4093-B53E-2CE12E95C7F1

P407

Q34426585-B45EB0AA-D793-460A-802D-37EFEDA4675B

P433

Q34426585-86CB5A41-BBB8-46A8-8D50-E0580E2A1E46

P478

Q34426585-1A12CAB1-BFF9-44E9-8BD2-349B0FF06C05

P50

Q34426585-3A2544A3-04AF-4944-B64F-066F85E99C3C

Q34426585-8FAFC4E1-01FB-48AB-8C51-8874CD48105D

Q34426585-940BF523-03ED-4960-8849-834679366F7C

Q34426585-AB507B73-2C87-4612-A90A-64BFCA910BA6

Q34426585-D8DF4A85-8F15-483F-A9AF-86DF5F46FEC9

P577

Q34426585-C064174B-45B4-46D3-BED5-FB886EFC7FB9

P5875

Q34426585-D5D06F11-B590-4BFC-B029-3318A1A45358

P6179

Q34426585-639C1520-EE71-4D4C-9867-FD24BC8F614C

P698

Q34426585-5B7F0662-3958-4951-BE41-682880C79E7D

P921

Q34426585-A32CAFA5-DC8C-4D55-BA79-7BFDE1C4D47E

Q34426585-E41B19D6-170C-4966-ADB2-5F64C1C33955

P932

Q34426585-4F8B8BE8-D7DD-4F7B-B769-05D796B7E5A7

P356

P1433

P1476

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

@en

P2093

Alexander Bello

http://www.w3.org/2001/XMLSchema#string

Ashley Johnson

http://www.w3.org/2001/XMLSchema#string

Bianli Xu

http://www.w3.org/2001/XMLSchema#string

Do Kim

http://www.w3.org/2001/XMLSchema#string

Ernie Hiatt

http://www.w3.org/2001/XMLSchema#string

Gene G Olinger

http://www.w3.org/2001/XMLSchema#string

Haiyan Wei

http://www.w3.org/2001/XMLSchema#string

Hugues Fausther-Bovendo

http://www.w3.org/2001/XMLSchema#string

James E Strong

http://www.w3.org/2001/XMLSchema#string

James Pettitt

http://www.w3.org/2001/XMLSchema#string

P2860

Effective post-exposure treatment of Ebola infection

Clinical management of filovirus-infected patients

Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb

Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques

Emergence of Zaire Ebola Virus Disease in Guinea

Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant.

Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors.

Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys.

Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions.

Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study.

P2888

P304

47-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NATURE13777

http://www.w3.org/2001/XMLSchema#string

P407

P433

7520

http://www.w3.org/2001/XMLSchema#string

P478

514

http://www.w3.org/2001/XMLSchema#string

P50

Charles Goodman

Gary P. Kobinger

P577

2014-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265177641

http://www.w3.org/2001/XMLSchema#string

P6179

1027386396

http://www.w3.org/2001/XMLSchema#string

P698

25171469

http://www.w3.org/2001/XMLSchema#string

P921

Ebola virus disease

P932

4214273

http://www.w3.org/2001/XMLSchema#string